Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16
- 15 May 2001
- Vol. 19 (25-26) , 3583-3590
- https://doi.org/10.1016/s0264-410x(01)00070-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- High throughput method for creating and screening recombinant adenovirusesGene Therapy, 1998
- Expression of Human Papillomavirus Type 16 L1 Protein inEscherichia coli:Denaturation, Renaturation, and Self-Assembly of Virus-like Particlesin VitroVirology, 1998
- T Cell Proliferative Responses Against Human Papillomavirus Type 16 E7 Oncoprotein are Most Prominent in Cervical Intraepithelial Neoplasia Patients with a Persistent Viral InfectionJournal of General Virology, 1996
- Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaquesNature Medicine, 1996
- Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic ImmunizationVirology, 1996
- A Replication-Defective Human Adenovirus Recombinant Serves as a Highly Efficacious Vaccine CarrierVirology, 1996
- Protection against Papillomavirus with a Polynucleotide VaccineThe Journal of Infectious Diseases, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Vaccination with a Plasmid Vector Carrying the Rabies Virus Glycoprotein Gene Induces Protective Immunity against Rabies VirusVirology, 1994
- Analysis of the L1 Gene Product of Human Papillomavirus Type 16 by Expression in a Vaccinia Virus RecombinantJournal of General Virology, 1988